New Hormonal Therapies for Breast Cancer. - Wikidata - awgldk - TriplyDB

New Hormonal Therapies for Breast Cancer.

New Hormonal Therapies for Breast Cancer.

http://www.wikidata.org/entity/Q54056103

about

New Hormonal Therapies for Breast Cancer.

http://www.wikidata.org/entity/Q54056103

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh

1999年學術文章

@zh-hant

name

New Hormonal Therapies for Breast Cancer.

@en

New Hormonal Therapies for Breast Cancer.

@nl

type

label

New Hormonal Therapies for Breast Cancer.

@en

New Hormonal Therapies for Breast Cancer.

@nl

prefLabel

New Hormonal Therapies for Breast Cancer.

@en

New Hormonal Therapies for Breast Cancer.

@nl

P1433

Q54056103-4C380D72-B5C5-4DDA-BE2C-FB988F2D1263

P1476

Q54056103-F4D56432-2074-45B1-8113-EADACBE8ACEC

P2093

Q54056103-922A8CB5-37E4-4C3F-AEFD-AA003B8D2D68

P2860

Q54056103-02DB7446-6D07-42F0-9469-1D780E9DCC0E

Q54056103-12131877-AE42-4FA8-9CD4-217B8B3A212D

Q54056103-183ADB4F-2860-4210-B7FA-2EB3CDA5A561

Q54056103-5A092918-C053-46F4-894C-B65FE2CC2E5F

Q54056103-711BF205-7BCC-456D-BAD2-2E01A67EEBCA

Q54056103-75C2755A-46BE-4278-B495-5E99DCB5EF05

Q54056103-75C94BB7-B158-4BA1-88B6-EDFECFB81FC1

Q54056103-95ECAC7A-6FCF-4AD7-AE34-75A634E2AE22

Q54056103-9D9D5314-1AF3-4FB3-AC87-6EF1C1DB93CC

Q54056103-9EB09F89-502F-42A1-A3D6-8997DC85BB3D

P304

Q54056103-5AC2FC71-995B-4B6F-9E1A-EE37440A28CF

P31

Q54056103-084BF4D0-A681-4FF5-9B6C-7C5FAD353D32

P356

Q54056103-EE129536-2FE2-4C63-B41E-BB085E281F31

P433

Q54056103-CBEF7BBE-8947-4250-8FF7-6063A0DAD1A0

P478

Q54056103-B3E051DD-800B-4518-952A-85D3D0A91293

P577

Q54056103-D0DD8211-DFA9-4133-8266-E246384AE3CD

P698

Q54056103-0CF8D354-034A-4089-A1D2-E88919A897C8

P356

107327489900600303

P1433

P1476

New Hormonal Therapies for Breast Cancer.

@en

P2093

Minton SE

http://www.w3.org/2001/XMLSchema#string

P2860

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats

Phase I/II study of the anti-oestrogen zindoxifene (D16726) in the treatment of advanced breast cancer. A Cancer Research Campaign Phase I/II Clinical Trials Committee study

Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study.

The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole.

Suicide enzyme inhibitors as potential drugs.

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

DNA adducts, mutations and cancer.

Experience with aromatase inhibitors in the treatment of advanced breast cancer.

P304

247-255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/107327489900600303

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

1999-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10758554

http://www.w3.org/2001/XMLSchema#string